Rallybio Corp - 8-K Filing

Rallybio Corp declares $82.7 million special cash distribution in connection with Avenzo Therapeutics merger (Items: 8.01 Other Events)

2 articles from 1 source · updated October 26, 2026, 20:58 UTC

Coverage

• Rallybio Corp - 4 Filing SEC EDGAR · October 26, 2026, 20:57 UTC
• Rallybio Corp - 8-K Filing SEC EDGAR · October 26, 2026, 20:54 UTC